{"id":5547,"date":"2025-02-03T09:10:03","date_gmt":"2025-02-03T08:10:03","guid":{"rendered":"https:\/\/cnatm-1.betapage.de\/?p=5547"},"modified":"2025-02-03T09:11:39","modified_gmt":"2025-02-03T08:11:39","slug":"microrna-basierte-therapie-der-copd","status":"publish","type":"post","link":"https:\/\/cnatm.de\/en\/microrna-basierte-therapie-der-copd\/","title":{"rendered":"microRNA-based therapy of COPD"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"5547\" class=\"elementor elementor-5547\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6363f8b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6363f8b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-807a88d\" data-id=\"807a88d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0b60e27 elementor-widget elementor-widget-heading\" data-id=\"0b60e27\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">microRNA-based therapy of COPD<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-39021d3 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"39021d3\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3c861fc\" data-id=\"3c861fc\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-553a889 elementor-widget elementor-widget-spacer\" data-id=\"553a889\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-39a4d74 elementor-widget elementor-widget-text-editor\" data-id=\"39a4d74\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Currently, there is no therapy that can interfere with the underlying inflammatory processes of COPD. Preliminary work on WP6 showed that the alveolar macrophage and its non-coding RNAs (ncRNAs) have a central role in the development of COPD. The aim of this WP is to develop antisense oligonucleotides against ncRNAs that, by coupling to a ligand, achieve enhanced uptake in alveolar macrophages and thus locally increased drug levels.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-72d739a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"72d739a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-89f255c\" data-id=\"89f255c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-89a1439 elementor-widget elementor-widget-text-editor\" data-id=\"89a1439\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Head: Stefan Engelhardt<br \/><\/strong><\/p><p><strong>PIs:<\/strong> Stefan Engelhardt, Ali \u00d6nder Yildirim<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-4e4729f\" data-id=\"4e4729f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4022c7e elementor-widget elementor-widget-text-editor\" data-id=\"4022c7e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>\u00a0Industrial partner<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-427c9f8 elementor-arrows-position-inside elementor-pagination-position-outside elementor-widget elementor-widget-image-carousel\" data-id=\"427c9f8\" data-element_type=\"widget\" data-settings=\"{&quot;slides_to_show&quot;:&quot;1&quot;,&quot;navigation&quot;:&quot;both&quot;,&quot;autoplay&quot;:&quot;yes&quot;,&quot;pause_on_hover&quot;:&quot;yes&quot;,&quot;pause_on_interaction&quot;:&quot;yes&quot;,&quot;autoplay_speed&quot;:5000,&quot;infinite&quot;:&quot;yes&quot;,&quot;effect&quot;:&quot;slide&quot;,&quot;speed&quot;:500}\" data-widget_type=\"image-carousel.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-image-carousel-wrapper swiper\" role=\"region\" aria-roledescription=\"carousel\" aria-label=\"Image Carousel\" dir=\"ltr\">\n\t\t\t<div class=\"elementor-image-carousel swiper-wrapper swiper-image-stretch\" aria-live=\"off\">\n\t\t\t\t\t\t\t\t<div class=\"swiper-slide\" role=\"group\" aria-roledescription=\"slide\" aria-label=\"1 of 2\"><figure class=\"swiper-slide-inner\"><img decoding=\"async\" class=\"swiper-slide-image\" src=\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/09\/Isar_Biosciences_GmbH-768x230.png\" alt=\"Isar Biosciences GmbH\" \/><\/figure><\/div><div class=\"swiper-slide\" role=\"group\" aria-roledescription=\"slide\" aria-label=\"2 of 2\"><figure class=\"swiper-slide-inner\"><img decoding=\"async\" class=\"swiper-slide-image\" src=\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/09\/Secarna_GmbH-768x230.png\" alt=\"Secarna GmbH\" \/><\/figure><\/div>\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-swiper-button elementor-swiper-button-prev\" role=\"button\" tabindex=\"0\">\n\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"eicon-chevron-left\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"elementor-swiper-button elementor-swiper-button-next\" role=\"button\" tabindex=\"0\">\n\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"eicon-chevron-right\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div class=\"swiper-pagination\"><\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>microRNA-basierte Therapie der COPD Die chronisch-obstruktive Lungenerkrankung (COPD) ist weltweit die dritth\u00e4ufigste Todesursache. Derzeit gibt es keine Therapie, die in die zugrundeliegenden Entz\u00fcndungsprozesse der COPD eingreifen kann. Vorarbeiten zu WP6 zeigten, dass der Alveolarmakrophage und seine nicht-kodierenden RNAs (ncRNAs) eine zentrale Rolle in der Entstehung von COPD haben. Ziel dieses WP ist, Antisense-Oligonukleotide gegen ncRNAs [&hellip;]<\/p>","protected":false},"author":11,"featured_media":5548,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[74],"tags":[],"class_list":["post-5547","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oligonukleotide-und-ihr-gezieltes-delivery"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>microRNA-basierte Therapie der COPD - CNATM<\/title>\n<meta name=\"description\" content=\"Die chronisch-obstruktive Lungenerkrankung (COPD) ist weltweit die dritth\u00e4ufigste Todesursache. Derzeit gibt es keine Therapie, die in die zugrundeliegenden Entz\u00fcndungsprozesse der COPD eingreifen kann.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cnatm.de\/en\/microrna-basierte-therapie-der-copd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"microRNA-basierte Therapie der COPD - CNATM\" \/>\n<meta property=\"og:description\" content=\"Die chronisch-obstruktive Lungenerkrankung (COPD) ist weltweit die dritth\u00e4ufigste Todesursache. Derzeit gibt es keine Therapie, die in die zugrundeliegenden Entz\u00fcndungsprozesse der COPD eingreifen kann.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cnatm.de\/en\/microrna-basierte-therapie-der-copd\/\" \/>\n<meta property=\"og:site_name\" content=\"CNATM\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-03T08:10:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-03T08:11:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP6.png\" \/>\n\t<meta property=\"og:image:width\" content=\"916\" \/>\n\t<meta property=\"og:image:height\" content=\"660\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Patrizia Torelli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patrizia Torelli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/\"},\"author\":{\"name\":\"Patrizia Torelli\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e\"},\"headline\":\"microRNA-basierte Therapie der COPD\",\"datePublished\":\"2025-02-03T08:10:03+00:00\",\"dateModified\":\"2025-02-03T08:11:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/\"},\"wordCount\":91,\"publisher\":{\"@id\":\"https:\/\/cnatm.de\/#organization\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP6.png\",\"articleSection\":[\"Oligonukleotide und ihr gezieltes Delivery\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/\",\"url\":\"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/\",\"name\":\"microRNA-basierte Therapie der COPD - CNATM\",\"isPartOf\":{\"@id\":\"https:\/\/cnatm.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP6.png\",\"datePublished\":\"2025-02-03T08:10:03+00:00\",\"dateModified\":\"2025-02-03T08:11:39+00:00\",\"description\":\"Die chronisch-obstruktive Lungenerkrankung (COPD) ist weltweit die dritth\u00e4ufigste Todesursache. Derzeit gibt es keine Therapie, die in die zugrundeliegenden Entz\u00fcndungsprozesse der COPD eingreifen kann.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/#primaryimage\",\"url\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP6.png\",\"contentUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP6.png\",\"width\":916,\"height\":660,\"caption\":\"microRNA-basierte Therapie der COPD\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cnatm.de\/#website\",\"url\":\"https:\/\/cnatm.de\/\",\"name\":\"CNATM\",\"description\":\"Cluster for Nucleic Acid Therapeutics Munich\",\"publisher\":{\"@id\":\"https:\/\/cnatm.de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cnatm.de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cnatm.de\/#organization\",\"name\":\"CNATM\",\"url\":\"https:\/\/cnatm.de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg\",\"contentUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg\",\"width\":2362,\"height\":479,\"caption\":\"CNATM\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e\",\"name\":\"Patrizia Torelli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"caption\":\"Patrizia Torelli\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"microRNA-basierte Therapie der COPD - CNATM","description":"Die chronisch-obstruktive Lungenerkrankung (COPD) ist weltweit die dritth\u00e4ufigste Todesursache. Derzeit gibt es keine Therapie, die in die zugrundeliegenden Entz\u00fcndungsprozesse der COPD eingreifen kann.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cnatm.de\/en\/microrna-basierte-therapie-der-copd\/","og_locale":"en_US","og_type":"article","og_title":"microRNA-basierte Therapie der COPD - CNATM","og_description":"Die chronisch-obstruktive Lungenerkrankung (COPD) ist weltweit die dritth\u00e4ufigste Todesursache. Derzeit gibt es keine Therapie, die in die zugrundeliegenden Entz\u00fcndungsprozesse der COPD eingreifen kann.","og_url":"https:\/\/cnatm.de\/en\/microrna-basierte-therapie-der-copd\/","og_site_name":"CNATM","article_published_time":"2025-02-03T08:10:03+00:00","article_modified_time":"2025-02-03T08:11:39+00:00","og_image":[{"width":916,"height":660,"url":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP6.png","type":"image\/png"}],"author":"Patrizia Torelli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Patrizia Torelli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/#article","isPartOf":{"@id":"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/"},"author":{"name":"Patrizia Torelli","@id":"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e"},"headline":"microRNA-basierte Therapie der COPD","datePublished":"2025-02-03T08:10:03+00:00","dateModified":"2025-02-03T08:11:39+00:00","mainEntityOfPage":{"@id":"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/"},"wordCount":91,"publisher":{"@id":"https:\/\/cnatm.de\/#organization"},"image":{"@id":"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/#primaryimage"},"thumbnailUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP6.png","articleSection":["Oligonukleotide und ihr gezieltes Delivery"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/","url":"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/","name":"microRNA-basierte Therapie der COPD - CNATM","isPartOf":{"@id":"https:\/\/cnatm.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/#primaryimage"},"image":{"@id":"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/#primaryimage"},"thumbnailUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP6.png","datePublished":"2025-02-03T08:10:03+00:00","dateModified":"2025-02-03T08:11:39+00:00","description":"Die chronisch-obstruktive Lungenerkrankung (COPD) ist weltweit die dritth\u00e4ufigste Todesursache. Derzeit gibt es keine Therapie, die in die zugrundeliegenden Entz\u00fcndungsprozesse der COPD eingreifen kann.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/microrna-basierte-therapie-der-copd\/#primaryimage","url":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP6.png","contentUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP6.png","width":916,"height":660,"caption":"microRNA-basierte Therapie der COPD"},{"@type":"WebSite","@id":"https:\/\/cnatm.de\/#website","url":"https:\/\/cnatm.de\/","name":"CNATM","description":"Cluster for Nucleic Acid Therapeutics Munich","publisher":{"@id":"https:\/\/cnatm.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cnatm.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cnatm.de\/#organization","name":"CNATM","url":"https:\/\/cnatm.de\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/#\/schema\/logo\/image\/","url":"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg","contentUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg","width":2362,"height":479,"caption":"CNATM"},"image":{"@id":"https:\/\/cnatm.de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e","name":"Patrizia Torelli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","caption":"Patrizia Torelli"}}]}},"_links":{"self":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5547","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/comments?post=5547"}],"version-history":[{"count":4,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5547\/revisions"}],"predecessor-version":[{"id":5552,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5547\/revisions\/5552"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/media\/5548"}],"wp:attachment":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/media?parent=5547"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/categories?post=5547"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/tags?post=5547"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}